Table of Contents Author Guidelines Submit a Manuscript
Journal of Biomedicine and Biotechnology
Volume 2010, Article ID 242539, 8 pages
http://dx.doi.org/10.1155/2010/242539
Review Article

Recent Advancements in Cytotoxic T Lymphocyte Generation Methods Using Carbohydrate-Coated Liposomes

Molecular Medicine Team of Research Center for Medical Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST), Tsukuba, Ibaraki 305-8568, Japan

Received 29 January 2010; Accepted 22 April 2010

Academic Editor: Hanchun Yang

Copyright © 2010 Yuzuru Ikehara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Ikehara, T. Niwa, L. Biao et al., “A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle,” Cancer Research, vol. 66, no. 17, pp. 8740–8748, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Ikehara, N. Shiuchi, S. Kabata-Ikehara et al., “Effective induction of anti-tumor immune responses with oligomannose-coated liposome targeting to intraperitoneal phagocytic cells,” Cancer Letters, vol. 260, no. 1-2, pp. 137–145, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Sakaguchi, R. Setoguchi, H. Yagi, and T. Nomura, “Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease,” Current Topics in Microbiology and Immunology, vol. 305, pp. 51–66, 2006. View at Google Scholar · View at Scopus
  4. R.-F. Wang, G. Peng, and H. Y. Wang, “Regulatory T cells and Toll-like receptors in tumor immunity,” Seminars in Immunology, vol. 18, no. 2, pp. 136–142, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. R. M. Zinkernagel, “Immunology taught by viruses,” Science, vol. 271, no. 5246, pp. 173–178, 1996. View at Google Scholar · View at Scopus
  6. A. M. Leen, C. M. Rooney, and A. E. Foster, “Improving T cell therapy for cancer,” Annual Review of Immunology, vol. 25, pp. 243–265, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. S. A. Rosenberg, “Progress in the development of immunotherapy for the treatment of patients with cancer,” Journal of Internal Medicine, vol. 250, no. 6, pp. 462–475, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. S. A. Rosenberg, J. C. Yang, and N. P. Restifo, “Cancer immunotherapy: moving beyond current vaccines,” Nature Medicine, vol. 10, no. 9, pp. 909–915, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. N. Kojima, L. Biao, T. Nakayama, M. Ishii, Y. Ikehara, and K. Tsujimura, “Oligomannose-coated liposomes as a therapeutic antigen-delivery and an adjuvant vehicle for induction of in vivo tumor immunity,” Journal of Controlled Release, vol. 129, no. 1, pp. 26–32, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Nishikawa, H. Zhang, Y. Ikehara, N. Kojima, X. Xuan, and N. Yokoyama, “Immunization with oligomannose-coated liposome-entrapped dense granule protein 7 protects dams and offspring from Neospora caninum infection in mice,” Clinical and Vaccine Immunology, vol. 16, no. 6, pp. 792–797, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Zhang, Y. Nishikawa, J. Yamagishi et al., “Neospora caninum: application of apical membrane antigen 1 encapsulated in the oligomannose-coated liposomes for reduction of offspring mortality from infection in BALB/c mice,” Experimental Parasitology, vol. 125, no. 2, pp. 130–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Hagiwara, T. Takahashi, K. Sawai et al., “Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice,” Cancer Research, vol. 53, no. 3, pp. 687–692, 1993. View at Google Scholar · View at Scopus
  13. E. Mandache, E. Moldoveanu, and G. Savi, “The involvement of omentum and its milky spots in the dynamics of peritoneal macrophages,” Morphologie et Embryologie, vol. 31, no. 2, pp. 137–142, 1985. View at Google Scholar · View at Scopus
  14. H. F. J. Dullens, L. H. P. M. Rademakers, S. Cluistra et al., “Parathymic lymph nodes during growth and rejection of intraperitoneally inoculated tumor cells,” Invasion and Metastasis, vol. 11, no. 4, pp. 216–226, 1991. View at Google Scholar · View at Scopus
  15. C. Hodel, “Ultrastructural studies on the absorption of protein markers by the greater omentum,” European Surgical Research, vol. 2, no. 6, pp. 435–449, 1970. View at Google Scholar · View at Scopus
  16. L. Gattinoni, D. J. Powell Jr., S. A. Rosenberg, and N. P. Restifo, “Adoptive immunotherapy for cancer: building on success,” Nature Reviews Immunology, vol. 6, no. 5, pp. 383–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. V. Racanelli and T. Manigold, “Presentation of HCV antigens to naive CD8+T cells: why the where, when, what and how are important for virus control and infection outcome,” Clinical Immunology, vol. 124, no. 1, pp. 5–12, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. C. R. Alving, V. Koulchin, G. M. Glenn, and M. Rao, “Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides,” Immunological Reviews, no. 145, pp. 5–31, 1995. View at Google Scholar · View at Scopus
  19. G. Chikh and M.-P. Schutze-Redelmeir, “Liposomal delivery of CTL epitopes to dendritic cells,” Bioscience Reports, vol. 22, no. 2, pp. 339–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. N. M. Wassef, C. R. Alving, and R. L. Richards, “Liposomes as carriers for vaccines,” ImmunoMethods, vol. 4, no. 3, pp. 217–222, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Kovacsovics-Bankowski and K. L. Rock, “A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules,” Science, vol. 267, no. 5195, pp. 243–246, 1995. View at Google Scholar · View at Scopus
  22. C. R. Alving and N. M. Wassef, “Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation,” AIDS Research and Human Retroviruses, vol. 10, no. 2, pp. S91–S94, 1994. View at Google Scholar · View at Scopus
  23. G. G. Chikh, S. Kong, M. B. Bally, J.-C. Meunier, and M.-P. M. Schutze-Redelmeier, “Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells,” Journal of Immunology, vol. 167, no. 11, pp. 6462–6470, 2001. View at Google Scholar · View at Scopus
  24. M.-P. Schutze-Redelmeier, H. Gournier, F. Garcia-Pons et al., “Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo,” Journal of Immunology, vol. 157, no. 2, pp. 650–655, 1996. View at Google Scholar · View at Scopus
  25. K.-D. Lee, Y.-K. Oh, D. A. Portnoy, and J. A. Swanson, “Delivery of macromolecules into cytosol using liposomes containing hemolysin from Listeria monocytogenes,” Journal of Biological Chemistry, vol. 271, no. 13, pp. 7249–7252, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Nakanishi, A. Hayashi, J. Kunisawa et al., “Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway,” European Journal of Immunology, vol. 30, no. 6, pp. 1740–1747, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Ishiwata, S. B. Sato, S. Kobayashi, M. Oku, A. Vertut-Doï, and K. Miyajima, “Poly(ethylene glycol) derivative of cholesterol reduces binding step of liposome uptake by murine macrophage-like cell line J774 and human hepatoma cell line HepG2,” Chemical and Pharmaceutical Bulletin, vol. 46, no. 12, pp. 1907–1913, 1998. View at Google Scholar · View at Scopus
  28. G. Chikh, M. Bally, and M.-P. Schutze-Redelmeier, “Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes,” Journal of Immunological Methods, vol. 254, no. 1-2, pp. 119–135, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. D. D. Lasic, F. J. Martin, A. Gabizon, S. K. Huang, and D. Papahadjopoulos, “Sterically stabilized liposomes: a hypothesis on the molecular origin of the extended circulation times,” Biochimica et Biophysica Acta, vol. 1070, no. 1, pp. 187–192, 1991. View at Publisher · View at Google Scholar · View at Scopus
  30. H. Ishiwata, A. Vertut-Doi, T. Hirose, and K. Miyajima, “Physical-chemistry characteristics and biodistribution of poly(ethylene glycol)-coated liposomes using poly(oxyethylene) cholesteryl ether,” Chemical and Pharmaceutical Bulletin, vol. 43, no. 6, pp. 1005–1011, 1995. View at Google Scholar · View at Scopus
  31. A. A. Gabizon, H. Shmeeda, and S. Zalipsky, “Pros and cons of the liposome platform in cancer drug targeting,” Journal of Liposome Research, vol. 16, no. 3, pp. 175–183, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Ignatius, K. Mahnke, M. Rivera et al., “Presentation of proteins encapsulated in sterically stabilized liposomes by dendritic cells initiates CD8+ T-cell responses in vivo,” Blood, vol. 96, no. 10, pp. 3505–3513, 2000. View at Google Scholar · View at Scopus
  33. J. W. Conlan, L. Krishnan, G. E. Willick, G. B. Patel, and G. D. Sprott, “Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various Archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen, Listeria monocytogenes,” Vaccine, vol. 19, no. 25-26, pp. 3509–3517, 2001. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott, “Archaeosomes induce long-term CD8+ cytotoxic T cell response to entrapped soluble protein by the exogenous cytosolic pathway, in the absence of CD4+ T cell help,” Journal of Immunology, vol. 165, no. 9, pp. 5177–5185, 2000. View at Google Scholar · View at Scopus
  35. L. Krishnan, S. Sad, G. B. Patel, and G. D. Sprott, “The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo,” Journal of Immunology, vol. 166, no. 3, pp. 1885–1893, 2001. View at Google Scholar · View at Scopus
  36. T. Nakanishi, J. Kunisawa, A. Hayashi et al., “Positively charged liposome functions as an efficient immunoadjuvant in inducing immune responses to soluble proteins,” Biochemical and Biophysical Research Communications, vol. 240, no. 3, pp. 793–797, 1997. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Nakanishi, J. Kunisawa, A. Hayashi et al., “Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins,” Journal of Controlled Release, vol. 61, no. 1-2, pp. 233–240, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. B. Guy, N. Pascal, A. Françon et al., “Design, characterization and preclinical efficacy of a cationic lipid adjuvant for influenza split vaccine,” Vaccine, vol. 19, no. 13-14, pp. 1794–1805, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. T. Keler, V. Ramakrishna, and M. W. Fanger, “Mannose receptor-targeted vaccines,” Expert Opinion on Biological Therapy, vol. 4, no. 12, pp. 1953–1962, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. F. Sallusto, M. Cella, C. Danieli, and A. Lanzavecchia, “Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products,” Journal of Experimental Medicine, vol. 182, no. 2, pp. 389–400, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. P. Machy, K. Serre, and L. Leserman, “Class I-restricted presentation of exogenous antigen acquired by Fcγ receptor-mediated endocytosis is regulated in dendritic cells,” European Journal of Immunology, vol. 30, no. 3, pp. 848–857, 2000. View at Publisher · View at Google Scholar · View at Scopus
  42. K. Serre, P. Machy, J.-C. Grivel et al., “Efficient presentation of multivalent antigens targeted to various cell surface molecules of dendritic cells and surface Ig of antigen-specific B cells,” Journal of Immunology, vol. 161, no. 11, pp. 6059–6067, 1998. View at Google Scholar · View at Scopus
  43. P. Guermonprez, N. Khelef, E. Blouin et al., “The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the αMβ2 integrin (CD11b/CD18),” Journal of Experimental Medicine, vol. 193, no. 9, pp. 1035–1044, 2001. View at Publisher · View at Google Scholar · View at Scopus
  44. P. Guermonprez, C. Fayolle, M. J. Rojas, M. Rescigno, D. Ladant, and C. Leclerc, “In vivo receptor-mediated delivery of a recombinant invasive bacterial toxoid to CD11c+CD8αCD11bhigh dendritic cells,” European Journal of Immunology, vol. 32, no. 11, pp. 3071–3081, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. M. L. Albert, J.-I. Kim, and R. B. Birge, “α(v)β5 integrin recruits the CrkII-Dock180-Rac1 complex for phagocytosis of apoptotic cells,” Nature Cell Biology, vol. 2, no. 12, pp. 899–905, 2000. View at Publisher · View at Google Scholar · View at Scopus
  46. Y. Ikehara and N. Kojima, “Development of a novel oligomannose-coated liposome-based anticancer drug-delivery system for intraperitoneal cancer,” Current Opinion in Molecular Therapeutics, vol. 9, no. 1, pp. 53–61, 2007. View at Google Scholar · View at Scopus
  47. E. W. Adams, D. M. Ratner, P. H. Seeberger, and N. Hacohen, “Carbohydrate-mediated targeting of antigen to dendritic cells leads to enhanced presentation of antigen to T cells,” ChemBioChem, vol. 9, no. 2, pp. 294–303, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. J. S. Lam, H. Huang, and S. M. Levitz, “Effect of differential N-linked and O-linked mannosylation on recognition of fungal antigens by dendritic cells,” PLoS ONE, vol. 2, no. 10, article e1009, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Luong, J. S. Lam, J. Chen, and S. M. Levitz, “Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines,” Vaccine, vol. 25, no. 22, pp. 4340–4344, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. S. K. Singh, J. Stephani, M. Schaefer et al., “Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation,” Molecular Immunology, vol. 47, no. 2-3, pp. 164–174, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. K.-C. Sheng, M. Kalkanidis, D. S. Pouniotis, M. D. Wright, G. A. Pietersz, and V. Apostolopoulos, “The adjuvanticity of a mannosylated antigen reveals TLR4 functionality essential for subset specialization and functional maturation of mouse dendritic cells,” Journal of Immunology, vol. 181, no. 4, pp. 2455–2464, 2008. View at Google Scholar · View at Scopus
  52. T. Mizuochi, R. W. Loveless, A. M. Lawson et al., “A library of oligosaccharide probes (neoglycolipids) from N-glycosylated proteins reveals that conglutinin binds to certain complex-type as well as high mannose-type oligosaccharide chains,” Journal of Biological Chemistry, vol. 264, no. 23, pp. 13834–13839, 1989. View at Google Scholar · View at Scopus
  53. Y. Shimizu, K. Yamakami, T. Gomi et al., “Protection against Leishmania major infection by oligomannose-coated liposomes,” Bioorganic and Medicinal Chemistry, vol. 11, no. 7, pp. 1191–1195, 2003. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Burke, “Macrophages as novel cellular vehicles for gene therapy,” Expert Opinion on Biological Therapy, vol. 3, no. 6, pp. 919–924, 2003. View at Publisher · View at Google Scholar · View at Scopus
  55. S. R. Clarke, M. Barnden, C. Kurts, F. R. Carbone, J. F. Miller, and W. R. Heath, “Characterization of the ovalbumin-specific TCR transgenic line OT-I: MHC elements for positive and negative selection,” Immunology and Cell Biology, vol. 78, no. 2, pp. 110–117, 2000. View at Publisher · View at Google Scholar · View at Scopus
  56. K. A. Hogquist, S. C. Jameson, W. R. Heath, J. L. Howard, M. J. Bevan, and F. R. Carbone, “T cell receptor antagonist peptides induce positive selection,” Cell, vol. 76, no. 1, pp. 17–27, 1994. View at Publisher · View at Google Scholar · View at Scopus
  57. M. J. Barnden, J. Allison, W. R. Heath, and F. R. Carbone, “Defective TCR expression in transgenic mice constructed using cDNA-based α- and β-chain genes under the control of heterologous regulatory elements,” Immunology and Cell Biology, vol. 76, no. 1, pp. 34–40, 1998. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Ishida, H. Harashima, and H. Kiwada, “Liposome clearance,” Bioscience Reports, vol. 22, no. 2, pp. 197–224, 2002. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Abe, Y. Kuroda, N. Kuboki, M. Matsushita, N. Yokoyama, and N. Kojima, “Contribution of complement component C3 and complement receptor type 3 to carbohydrate-dependent uptake of oligomannose-coated liposomes by peritoneal macrophages,” Journal of Biochemistry, vol. 144, no. 5, pp. 563–570, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. M. W. Turner, “Mannose-binding lectin: the pluripotent molecule of the innate immune system,” Immunology Today, vol. 17, no. 11, pp. 532–540, 1996. View at Publisher · View at Google Scholar · View at Scopus
  61. A. Avraméas, D. McIlroy, A. Hosmalin et al., “Expression of a mannose/fucose membrane lectin on human dendritic cells,” European Journal of Immunology, vol. 26, no. 2, pp. 394–400, 1996. View at Publisher · View at Google Scholar · View at Scopus
  62. D. A. Mitchell, A. J. Fadden, and K. Drickamer, “A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands,” Journal of Biological Chemistry, vol. 276, no. 31, pp. 28939–28945, 2001. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Takagi, M. Numazaki, T. Kajiwara et al., “Cooperation of specific ICAM-3 grabbing nonintegrin-related 1 (SIGNR1) and complement receptor type 3 (CR3) in the uptake of oligomannose-coated liposomes by macrophages,” Glycobiology, vol. 19, no. 3, pp. 258–266, 2009. View at Publisher · View at Google Scholar · View at Scopus
  64. B. M. Curtis, S. Scharnowske, and A. J. Watson, “Sequence and expression of a membrane-associated C-type lectin that exhibits CD4-independent binding of human immunodeficiency virus envelope glycoprotein gp120,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 17, pp. 8356–8360, 1992. View at Google Scholar · View at Scopus
  65. T. B. H. Geijtenbeek, R. Torensma, S. J. van Vliet et al., “Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses,” Cell, vol. 100, no. 5, pp. 575–585, 2000. View at Google Scholar · View at Scopus
  66. A. Engering, T. B. H. Geijtenbeek, S. J. van Vliet et al., “The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells,” Journal of Immunology, vol. 168, no. 5, pp. 2118–2126, 2002. View at Google Scholar · View at Scopus
  67. P. J. Tacken, I. J. M. de Vries, K. Gijzen et al., “Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody,” Blood, vol. 106, no. 4, pp. 1278–1285, 2005. View at Publisher · View at Google Scholar · View at Scopus
  68. R. A. B. Ezekowitz, D. J. Williams, H. Koziel et al., “Uptake of Pneumocystis carinii mediated by the macrophage mannose receptor,” Nature, vol. 351, no. 6322, pp. 155–158, 1991. View at Publisher · View at Google Scholar · View at Scopus
  69. L. Marodi, H. M. Korchak, and R. B. Johnston Jr., “Mechanisms of host defense against Candida species: I. Phagocytosis by monocytes and monocyte-derived macrophages,” Journal of Immunology, vol. 146, no. 8, pp. 2783–2789, 1991. View at Google Scholar · View at Scopus
  70. P. R. Taylor, S. Gordon, and L. Martinez-Pomares, “The mannose receptor: linking homeostasis and immunity through sugar recognition,” Trends in Immunology, vol. 26, no. 2, pp. 104–110, 2005. View at Publisher · View at Google Scholar · View at Scopus
  71. M. E. Taylor, K. Bezouska, and K. Drickamer, “Contribution to ligand binding by multiple carbohydrate-recognition domains in the macrophage mannose receptor,” Journal of Biological Chemistry, vol. 267, no. 3, pp. 1719–1726, 1992. View at Google Scholar · View at Scopus
  72. V. Ramakrishna, J. F. Treml, L. Vitale et al., “Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules,” Journal of Immunology, vol. 172, no. 5, pp. 2845–2852, 2004. View at Google Scholar · View at Scopus
  73. M. E. Taylor, J. T. Conary, M. R. Lennartz, P. D. Stahl, and K. Drickamer, “Primary structure of the mannose receptor contains multiple motifs resembling carbohydrate-recognition domains,” Journal of Biological Chemistry, vol. 265, no. 21, pp. 12156–12162, 1990. View at Google Scholar · View at Scopus
  74. H. Feinberg, S. Park-Snyder, A. R. Kolatkar, C. T. Heise, M. E. Taylor, and W. I. Weis, “Structure of a C-type carbohydrate recognition domain from the macrophage mannose receptor,” Journal of Biological Chemistry, vol. 275, no. 28, pp. 21539–21548, 2000. View at Publisher · View at Google Scholar · View at Scopus
  75. W. Jian, W. J. Swiggard, C. Heufler et al., “The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing,” Nature, vol. 375, no. 6527, pp. 151–155, 1995. View at Google Scholar · View at Scopus
  76. D. Hawiger, K. Inaba, Y. Dorsett et al., “Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo,” Journal of Experimental Medicine, vol. 194, no. 6, pp. 769–779, 2001. View at Publisher · View at Google Scholar · View at Scopus
  77. M. van Lookeren Campagne, C. Wiesmann, and E. J. Brown, “Macrophage complement receptors and pathogen clearance,” Cellular Microbiology, vol. 9, no. 9, pp. 2095–2102, 2007. View at Publisher · View at Google Scholar · View at Scopus
  78. J. Q. He, C. Wiesmann, and M. van Lookeren Campagne, “A role of macrophage complement receptor CRIg in immune clearance and inflammation,” Molecular immunology, vol. 45, no. 16, pp. 4041–4047, 2008. View at Publisher · View at Google Scholar · View at Scopus
  79. V. M. Holers, T. Kinoshita, and H. Molina, “The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function,” Immunology Today, vol. 13, no. 6, pp. 231–236, 1992. View at Google Scholar · View at Scopus
  80. M. C. Carroll, “The complement system in regulation of adaptive immunity,” Nature Immunology, vol. 5, no. 10, pp. 981–986, 2004. View at Publisher · View at Google Scholar · View at Scopus
  81. K. Y. Helmy, K. J. Katschke Jr., N. N. Gorgani et al., “CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens,” Cell, vol. 124, no. 5, pp. 915–927, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. L. Vogt, N. Schmitz, M. O. Kurrer et al., “VSIG4, a B7 family-related protein, is a negative regulator of T cell activation,” Journal of Clinical Investigation, vol. 116, no. 10, pp. 2817–2826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  83. X. Zang and J. P. Allison, “To be or not to be B7,” Journal of Clinical Investigation, vol. 116, no. 10, pp. 2590–2593, 2006. View at Publisher · View at Google Scholar · View at Scopus
  84. F. R. Toapanta and T. M. Ross, “Complement-mediated activation of the adaptive immune responses: role of C3d in linking the innate and adaptive immunity,” Immunologic Research, vol. 36, no. 1–3, pp. 197–210, 2006. View at Google Scholar · View at Scopus
  85. M. R. W. Ehlers, “CR3: a general purpose adhesion-recognition receptor essential for innate immunity,” Microbes and Infection, vol. 2, no. 3, pp. 289–294, 2000. View at Publisher · View at Google Scholar · View at Scopus
  86. S. Bertholet, A. Debrabant, F. Afrin et al., “Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells,” Infection and Immunity, vol. 73, no. 10, pp. 6620–6628, 2005. View at Publisher · View at Google Scholar · View at Scopus
  87. F. Dzierszinski, M. Pepper, J. S. Stumhofer et al., “Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells,” Infection and Immunity, vol. 75, no. 11, pp. 5200–5209, 2007. View at Publisher · View at Google Scholar · View at Scopus
  88. D. J. Mckeever, “Theileria parva and the bovine CTL response: down but not out?” Parasite Immunology, vol. 28, no. 7, pp. 339–345, 2006. View at Publisher · View at Google Scholar · View at Scopus
  89. J. S. Ahmed, E. J. Glass, D. A. Salih, and U. Seitzer, “Innate immunity to tropical theileriosis,” Innate Immunity, vol. 14, no. 1, pp. 5–12, 2008. View at Publisher · View at Google Scholar · View at Scopus
  90. G. Conze, J. D. M. Campbell, A. K. Nichani, E. J. Glass, R. L. Spooner, and J. S. Ahmed, “Evidence for strain specificity in cytotoxic T-lymphocyte-mediated, major histocompatibility complex class I-dependent killing of Theileria annulata-infected cells,” Parasitology Research, vol. 84, no. 7, pp. 593–595, 1998. View at Publisher · View at Google Scholar · View at Scopus
  91. W. I. Morrison, B. M. Goddeeris, A. J. Teale et al., “Cytotoxic T-cells elicited in cattle challenged with Theileria parva (Muguga): evidence for restriction by class I MHC determinants and parasite strain specificity,” Parasite Immunology, vol. 9, no. 5, pp. 563–578, 1987. View at Google Scholar · View at Scopus
  92. G. Di Giulio, G. Lynen, S. Morzaria, C. Oura, and R. Bishop, “Live immunization against East Coast fever—current status,” Trends in Parasitology, vol. 25, no. 2, pp. 85–92, 2009. View at Publisher · View at Google Scholar · View at Scopus
  93. U. Seitzer and J. Ahmed, “Tropical theileriosis: cytotoxic T lymphocyte response to vaccination,” Vaccine, vol. 26, pp. G24–28, 2008. View at Publisher · View at Google Scholar · View at Scopus
  94. K. Ewer, J. Deeks, L. Alvarez et al., “Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak,” The Lancet, vol. 361, no. 9364, pp. 1168–1173, 2003. View at Publisher · View at Google Scholar · View at Scopus